Analystreport

ZEALAND PHARMA/S (NASDAQ: ZEAL) was given a new $29.00 price target on by analysts at Morgan Stanley. They now have a "buy" rating on the stock.

Zealand Pharma A/S - American Depositary Shares  (ZEAL) 
Last zealand pharma a/s - american depositary shares earnings: 11/15 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: zealandpharma.com